Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Effective PCOS treatments require targeting specific signaling pathways.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Hair follicles can help diagnose traumatic brain injury quickly and non-invasively.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Understanding and treating alopecia areata improves patient care.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Individualized treatment and psychological support are crucial for alopecia.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Numerical methods help analyze alopecia drugs' properties effectively.

Using neurohormones to control keratin can lead to new skin disease treatments.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.